Cargando…
Effects of diabetic pharmacotherapy on prolactin hormone in patients with type 2 diabetes mellitus: Bane or Boon
Prolactin is a polypeptide hormone secreted from the anterior part of the pituitary gland which was implicated as a diabetogenic factor in the pathogenesis of type 2 diabetes mellitus (T2DM). Therefore, the aim of the present study was to evaluate prolactin serum levels in patients with T2DM regardi...
Autores principales: | Rasheed, Huda Abdulbaki, Al-Kuraishy, Hayder M., Al-Gareeb, Ali I., Hussien, Nawar Raad, Al-Nami, Marwa S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844004/ https://www.ncbi.nlm.nih.gov/pubmed/31742116 http://dx.doi.org/10.4103/japtr.JAPTR_65_19 |
Ejemplares similares
-
Testosterone in COVID-19: An Adversary Bane or Comrade Boon
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021) -
Metabolic profile and prolactin serum levels in men with type 2 diabetes mellitus: Old-new rubric
por: Al-Nami, Marwa S., et al.
Publicado: (2019) -
Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
por: Alsubaie, Nawal, et al.
Publicado: (2022) -
Assessment of serum prolactin levels in acute myocardial infarction: The role of pharmacotherapy
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2016) -
Levothyroxine improves Paraoxonase (PON-1) serum levels in patients with primary hypothyroidism: Case–control study
por: Al-Naimi, Marwa S., et al.
Publicado: (2018)